Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis

Journal of Gastroenterology

Volumn 49, Issue 6, 2014, Pages 961-970

  Kamisawa, Terumi ^a   Okazaki, Kazuichi ^b   Kawa, Shigeyuki ^c   Ito, Tetsuhide ^d   Inui, Kazuo ^e   Irie, Hiroyuki ^f   Nishino, Takayoshi ^g   Notohara, Kenji ^h   Nishimori, Isao ⁱ   Tanaka, Shigeki ^j   Nishiyama, Toshimasa ^b   Suda, Koichi ^k   Shiratori, Keiko ^g   Tanaka, Masao ^d   Shimosegawa, Tooru ^l   Kubo, Keishi ^m   Ohara, Hirotaka ⁿ   Irisawa, Atsushi ^o   Fujinaga, Yasunari ^m   Hasebe, Osamu ^p   Yamamoto, Hiroshi ^ad   Uchida, Kazushige ^b   Kanno, Atsushi ^l   Kubota, Kensuke ^q   Ko, Shigeru ^r   Sakagami, Junichi ^s   Shimizu, Kyoko ^g   Sugiyama, Masanori ^t   Tada, Minoru ^u   Nakazawa, Takahiro ^v   Nishino, Hirokazu ^w   Hamano, Hideaki ^x   Hirooka, Yoshiki ^y   Hirano, Kenji ^u   Masamune, Atsushi ^l   Masuda, Atsuhiro ^z   Mizuno, Nobumasa ^aa   Yamaguchi, Koji ^ab   Yoshida, Hitoshi ^ac   more..

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e FUJITA HEALTH UNIVERSITY BANTANE HOSPITAL   (Japan)

^f SAGA UNIVERSITY   (Japan)

^g TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^h KURASHIKI CENTRAL HOSPITAL   (Japan)

ⁱ Nishimori Clinic   (Japan)

^j TOKYO ARIAKE UNIVERSITY OF MEDICAL AND HEALTH SCIENCES   (Japan)

^k Tokyo west Tokushukai Hospital   (Japan)

^l TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^m SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^o FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^p Nagano Municipal Hospital   (Japan)

^q YOKOHAMA CITY UNIVERSITY   (Japan)

^r KEIO UNIVERSITY   (Japan)

^s KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^t KYORIN UNIVERSITY   (Japan)

^u UNIVERSITY OF TOKYO   (Japan)

^v NAGOYA CITY UNIVERSITY   (Japan)

^w JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^x SHINSHU UNIVERSITY HOSPITAL   (Japan)

^y NAGOYA UNIVERSITY HOSPITAL   (Japan)

^z KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^aa AICHI CANCER CENTER HOSPITAL   (Japan)

^ab UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^ac SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^ad Division of Gastroenterology Department of Internal Medicine Kobe University Graduate School of Medicine ^*

more..

Author keywords

Autoimmune pancreatitis; Guideline; Steroid; Treatment

Indexed keywords

AZATHIOPRINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; LIVER ENZYME; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; STEROID; GLUCOCORTICOID;

ABDOMINAL PAIN; ARTICLE; AUTOIMMUNE PANCREATITIS; BACKACHE; BILIARY TRACT DRAINAGE; BLOOD EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DIABETES MELLITUS; DISEASE ACTIVITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ENDOCRINE FUNCTION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GLUCOSE BLOOD LEVEL; HUMAN; JAPANESE (PEOPLE); LOW DRUG DOSE; MAINTENANCE THERAPY; MULTIPLE CYCLE TREATMENT; OBSTRUCTIVE JAUNDICE; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; RECOMMENDED DRUG DOSE; RELAPSE; STEROID THERAPY; TREATMENT DURATION; TREATMENT INDICATION; ULTRASOUND; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOIMMUNE DISEASES; CONSENSUS; IMMUNOLOGY; PANCREATITIS; PRACTICE GUIDELINE; RECURRENT DISEASE; TREATMENT OUTCOME;

ASIAN CONTINENTAL ANCESTRY GROUP; AUTOIMMUNE DISEASES; CONSENSUS; GLUCOCORTICOIDS; HUMANS; PANCREATITIS; PROGNOSIS; RECURRENCE; TREATMENT OUTCOME;

EID: 84902360124     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-014-0945-z     Document Type: Article

References (57)

1. Wakabayashi T, Kawaura Y, Satomura Y, et al. Long-term prognosis of duct-narrowing chronic pancreatitis. Strategy for steroid treatment. Strategy for steroid treatment. Pancreas. 2005;30:31-9. (Pubitemid 40070624)
2. Kamisawa T, Yoshiike M, Egawa N, et al. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology. 2005;5:234-40.
3. Kubota K, Iida H, Fujisawa T, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc. 2007;66:1142-51. (Pubitemid 350186013)
4. Ozden I, Dizdaroglu F, Poyanli A, et al. Spontaneous regression of a pancreatic head mass and biliary obstruction due to autoimmune pancreatitis. Pancreatology. 2005;5:300-3. (Pubitemid 40754754)
5. Araki J, Tsujimoto F, Ohta T, et al. Natural course of autoimmune pancreatitis without steroid therapy showing hypoechoic masses in the uncinate process and tail of the pancreas on ultrasonography. J Ultrasound Med. 2006;25:1063-7. (Pubitemid 44157339)
6. Nishimori I, Okazaki K, Kawa S, et al. Treatment for autoimmune pancreatitis. J Biliary Tract Pancreas (in Japanese). 2007;28:961-6.
7. Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicenter, international analysis. Gut. 2013;62:1771-6.
8. Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol. 2006;41:613-25. (Pubitemid 44288524)
9. Nishimori I, Okazaki K, Suda K, et al. Treatment for autoimmune pancreatitis. Consensus of treatment for autoimmune pancreatitis by research committee of intractable pancreatic diseases supported by Ministry of Health, Labour and Welfare of Japan - Suizou. 2005;20:343-8 (in Japanese).
10. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut. 2009;58:1504-7.
11. Kamisawa T, Okamoto A, Wakabayashi T, et al. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome. Scand J Gastroenterl. 2008;43:609-13. (Pubitemid 351536059)
12. Kamisawa T, Egawa N, Inokuma S, et al. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy. Pancreas. 2003;27:235-8. (Pubitemid 37205870)
13. Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41:626-31. (Pubitemid 44288525)
14. Pearson RK, Longnecker DS, Chari ST, et al. Controversies in clinical pancreatology. Autoimmune pancreatitis: does it exist? Pancreas. 2003;27:1-13. (Pubitemid 36775972)
15. Ghazale A, Chari ST. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut. 2007;56:1650-2. (Pubitemid 350206287)
16. Finkelberg DL, Sahani D, Deshpande V, et al. Autoimmune pancreatitis. N Engl J Med. 2006;355:2670-6. (Pubitemid 44969126)
17. Park DH, Kim MH, Oh HB, et al. Substitution of aspartic acid at position 57 of the DQb1 affects relapse of autoimmune pancreatitis. Gastroenterology. 2008;134:440-6. (Pubitemid 351173047)
18. Matsushita M, Yamashina M, Ikeura T, et al. Effective steroid pulse therapy for the biliary stenosis caused by autoimmune pancreatitis. Am J Gastroenterol. 2007;102:220-1. (Pubitemid 46072085)
19. Kamisawa T, Egawa N, Nakajima H, et al. Morphological changes after steroid therapy in autoimmune pancreatitis. Scand J Gastroenterol. 2004;11:1154-8. (Pubitemid 39536407)
20. Kamisawa T, Okazaki K, Kawa S, et al. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol. 2010;45:471-7.
21. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706-15. (Pubitemid 351312724)
22. Raina A, Yadav D, Krasinskas AM, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol. 2009;104:2295-306.
23. Nishimori I, Otsuki M. Study on steroid therapy for autoimmune pancreatitis. Annual reports of research committee of intractable pancreatic diseases supported by Ministry of Health, Labour and Welfare of Japan. 2008;137-44 (in Japanese).
24. Nishino T, Toki F, Oyama H, et al. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med. 2006;45:497-501.
25. Naitoh I, Nakazawa T, Ohara H, et al. Clinical significance of extrapancreatic lesions in autoimmune pancreatitis. Pancreas. 2010;39:e1-5.
26. Hirano K, Tada M, Isayama H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut. 2007;56:1719-24. (Pubitemid 350206299)
27. Ko SB, Mizuno N, Yatabe Y, et al. Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis. Gastroenterology. 2010;138:1988-96.
28. Kawa S, Hamano H, Ozaki Y, et al. Long-term follow-up of autoimmune pancreatitis: characteristics of chronic disease and recurrence. Clin Gastroenterol Hepatol. 2009;7(11 Suppl):S18-22.
29. Sandanayake NS, Church NI, Chapman MH, et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol. 2009;7:1089-96.
30. Topazian M, Witzig TE, Smyrk TC, et al. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol. 2008;6:364-6. (Pubitemid 351318380)
31. Khosroshahi A, Bloch DB, Deshpande V, et al. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010;62:1755-62.
32. Naitoh I, Nakazawa T, Ohara H, et al. Autoimmune pancreatitis associated with various extrapancreatic lesions during a long-term clinical course successfully treated with azathioprine and corticosteroid maintenance therapy. Intern Med. 2009;48:2003-7.
33. Nishimori I, Tamakoshi A, Kawa S, et al. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan. Pancreas. 2006;32:244-8.
34. Ito T, Nishimori I, Inoue N, et al. Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol. 2007;42(Suppl 18):50-8. (Pubitemid 46863938)
35. Ito T, Kawabe K, Arita Y, et al. Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis. Pancreas. 2007;34:254-9. (Pubitemid 46294803)
36. Tanaka S, Kobayashi T, Nakanishi K, et al. Corticosteroidresponsive diabetes mellitus associated with autoimmune pancreatitis. Lancet. 2000;356:910-1.
37. Kamisawa T, Okamoto A. Prognosis of autoimmune pancreatitis. J Gastroenterol. 2007;42(supplement 18):59-62. (Pubitemid 46863939)
38. Uchida K, Yazumi S, Nishio A, et al. Long-term outcome of autoimmune pancreatitis. J Gastroenterol. 2009;44:726-32.
39. Ryu JK, Chung JB, Park SW, et al. Review of 67 patients with autoimmune pancreatitis in Korea. A multicenter nationwide study. Pancreas. 2008;37:377-85.
40. Sahani D, Sainani N, Deshpande V, et al. Autoimmune pancreatitis: disease evolution, staging, response assessment, and CT features that predict response to corticosteroid therapy. Radiology. 2009;250:118-29.
41. Frulloni L, Scattolini C, Falconi M, et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol. 2009;104:2288-94.
42. Noor MT, Lal A, Kochhar R, et al. Autoimmune pancreatitis: a report from India. JOP J Pancreas. 2010;11:213-9.
43. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. N Engl J Med. 1993;328:1422-7.
44. Takayama M, Hamano H, Ochi Y, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol. 2004;99:932-7. (Pubitemid 39090226)
45. Sakashita F, Tanahashi T, Yamaguchi K, et al. Case of pancreatic tail cancer associated with autoimmune pancreatitis. Jpn J Gastroenterol Surg. 2006;39:78-83. (Pubitemid 43096894)
46. Inoue H, Miyatani H, Sawada Y, et al. A case of pancreatic cancer with autoimmune pancreatitis. Pancreas. 2006;33:208-9. (Pubitemid 44174577)
47. Wayne M, Cooperman A, Kasmin F, et al. Chronic pancreatitis with synchronous and metachronous malignancy: three unusual cases and a literature review. J Surg Educ. 2007;64:158-61. (Pubitemid 46888360)
48. Fukui T, Mitsuya T, Takaoka M, et al. Pancreatic cancer associated with autoimmune pancreatitis in remission. Inter Med. 2008;47:151-5. (Pubitemid 351372627)
49. Ghazale A, Chari S. Is autoimmune pancreatitis a risk factor for pancreatic cancer? Pancreas. 2007;35:376. (Pubitemid 350307384)
50. Witkiewicz AK, Kennedy EP, Kennyon L, et al. Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature. Hum Pathol. 2008;39:1548-51.
51. Iida H, Kubota K, Mawatari H, et al. A case of autoimmune pancreatitis developed pancreatic tail cancer. Suizou. 2008;23:608-14.
52. Matsubayashi H, Matsunaga K, Uesaka K, et al. A case of pancreatic carcinoma with suspected autoimmune pancreatitis. Clin J Gastroenterol. 2009;2:59-63.
53. Motosugi U, Ichikawa T, Yamaguchi H, et al. Small invasive ductal adenocarcinoma of the pancreas associated with lymphoplasmacytic sclerosing pancreatitis. Pathol Int. 2009;59:744-7.
54. Tanaka S, Yoshida H, Ikegami K, et al. Treatment and prognosis of autoimmune pancreatitis. Suizo (in Japanese). 2007;22:663-71.
55. Song Y, Lui QD, Zhou NX, et al. Diagnosis and management of autoimmune pancreatitis: experience from China. World J Gastroenterol. 2008;14:601-6. (Pubitemid 351320828)
56. Kamisawa T, Tsuruta K, Okamoto A, et al. Frequent and significant K-ras mutation in the pancreas, the bile duct, and the gallbladder in autoimmune pancreatitis. Pancreas. 2009;38:890-5.
57. Notohara K, Wani Y, Tsukayama C, et al. Comparative study between pancreatic ductal carcinoma-associated histological changes and autoimmune pancreatitis. Annual reports of research committee of intractable pancreatic diseases supported by Ministry of Health, Labour and Welfare of Japan. 2008;246-50 (in Japanese).